DAVID CHARLES FOSTER

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Vulvar disease
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Obstet Gynecol 100:145-63. 2002
  2. ncbi Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Am J Obstet Gynecol 196:346.e1-8. 2007
  3. ncbi Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome
    David C Foster
    Division of Gynecologic Specialties, Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Reprod Med 49:503-9. 2004
  4. ncbi Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women
    David C Foster
    Department of Obstetrics and Gynecology and Department of Anaesthesia, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Pain 117:128-36. 2005
  5. ncbi The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Obstet Gynecol 113:825-32. 2009
  6. ncbi Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial
    David C Foster
    Departments of Obstetrics and Gynecology, Biostatistics, Anesthesiology and Neurology, and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Obstet Gynecol 116:583-93. 2010
  7. ncbi Contributions of physical and sexual abuse to women's experiences with chronic pelvic pain
    Ellen L Poleshuck
    Wynne Center for Family Research, Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Reprod Med 50:91-100. 2005
  8. ncbi The vulvodynia guideline
    Hope K Haefner
    Department of Obstetrics and Gynecology, University of Michigan Hospitals, Ann Arbor, MI 48109, USA
    J Low Genit Tract Dis 9:40-51. 2005
  9. ncbi A novel ELISpot method for adherent cells
    Chantal K Turner
    Department of Environmental Medicine, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA
    J Immunol Methods 291:63-70. 2004

Research Grants

  1. Vulvar vestibulitis trial: Desipramine-Lidocaine
    David Foster; Fiscal Year: 2006

Detail Information

Publications9

  1. ncbi Vulvar disease
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Obstet Gynecol 100:145-63. 2002
    ..This review of vulvar disease highlights a number of common and problematic vulvar conditions. Treatment options for vulvar conditions are covered with an expanded discussion of newer immune response modifiers...
  2. ncbi Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Am J Obstet Gynecol 196:346.e1-8. 2007
    ....
  3. ncbi Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome
    David C Foster
    Division of Gynecologic Specialties, Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Reprod Med 49:503-9. 2004
    ..To investigate the risk of vulvar vestibulitis syndrome (VVS) in the presence of specific genetic variants (polymorphisms) that affect chronic inflammation, pain and skin color...
  4. ncbi Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women
    David C Foster
    Department of Obstetrics and Gynecology and Department of Anaesthesia, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Pain 117:128-36. 2005
    ..Conclusion. VVS patients show enhancement of post-capsaicin pain response extending far beyond the anatomic location of the primary complaint...
  5. ncbi The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness
    David C Foster
    Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Obstet Gynecol 113:825-32. 2009
    ..We report upon the reliability, validity, and responsiveness to change of the Tampon Test as an outcome measure for vulvodynia clinical trials...
  6. ncbi Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial
    David C Foster
    Departments of Obstetrics and Gynecology, Biostatistics, Anesthesiology and Neurology, and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Obstet Gynecol 116:583-93. 2010
    ..To estimate the efficacy of common treatments for vulvodynia: topical lidocaine monotherapy, oral desipramine monotherapy, and lidocaine-desipramine combined therapy...
  7. ncbi Contributions of physical and sexual abuse to women's experiences with chronic pelvic pain
    Ellen L Poleshuck
    Wynne Center for Family Research, Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Reprod Med 50:91-100. 2005
    ..To examine the roles of physical and sexual abuse in women with chronic pelvic pain using multi-dimensional pain assessment and to compare the chronic pelvic pain experiences of women with physical abuse to those of women with sexual abuse...
  8. ncbi The vulvodynia guideline
    Hope K Haefner
    Department of Obstetrics and Gynecology, University of Michigan Hospitals, Ann Arbor, MI 48109, USA
    J Low Genit Tract Dis 9:40-51. 2005
    ..To provide a review of the literature and make known expert opinion regarding the treatment of vulvodynia...
  9. ncbi A novel ELISpot method for adherent cells
    Chantal K Turner
    Department of Environmental Medicine, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA
    J Immunol Methods 291:63-70. 2004
    ..Moreover, the assay is suitable for normal human adherent cells that are often short-lived and difficult to cultivate...

Research Grants5

  1. Vulvar vestibulitis trial: Desipramine-Lidocaine
    David Foster; Fiscal Year: 2006
    ..equally effective or is one superior to the other? Is there any benefit from combined local and systemic treatments? And finally, do genetic characteristics and tissue cytokine concentrations influence treatment response? ..